Patent US4612281A successfully refreshed from Google Patents.
US4612281A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immunoassay for detecting immunoglobulins and test kit
Assignee: Sutter Health
•
Filing: 1982-11-05
•
Granted: 1986-09-16
•
Expires: 2002-11-05
Abstract
Abstract An immunoassay for detecting disease associated Ig, such as IgM associated with acute forms of Toxoplasma gondii infection. Wells of microtiter plates are first coated with an antibody against the Ig to be detected and the test sample, e.g. serum, is then added and incubated. After removal of non-adsorbed materials from the wells, an insoluble visible form of the cognate antigen to the Ig, such as antigen fixed to latex particles, is added. If no such Ig is present in the sample, the antigen will appear as a smooth button on the bottom of the well; whereas if such Ig is present in significant quantity, the antigen will be captured by adsorbed antiIg-Ig complexes and distributed on the wall of the well according to the distribution of the antiIg-Ig complex thereon.
Inventors
- 👤 Georges Desmonts
- 👤 Jack S. Remington
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 11:50
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/6854; G01N33/53; G01N33/569; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/975; Y10S436/00; Y10S436/805; Y10S436/807; Y10S436/808; Y10S436/811
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
123 words
An immunoassay for detecting in a sample of body fluid an Ig that binds specifically to an antigen associated with a microorganism comprising the steps of: (a) adsorbing an antibody against said Ig onto the solid surface of a well-shaped container; (b) applying the sample to the adsorbed antibody against said Ig and incubating the resulting mixture; (c) separating the nonadsorbed fraction from the adsorbed fraction of the incubated mixture of step (b); (d) applying the microorganism as constituting an insoluble, opaque, directly observable form of the antigen to the adsorbed fraction; and (e) observing directly the extent to which the insoluble opaque antigen is bound to the adsorbed fraction by observing the distribution of the antigen on the wall of the container.
Claim 2
Dependent Claim
123 words
An immunoassay for detecting in a sample of body fluid an Ig that binds specifically to an antigen associated with a microorganism comprising the steps of: (a) adsorbing an antibody against said Ig onto the solid surface of a well-shaped container; (b) applying the sample to the adsorbed antibody against said Ig and incubating the resulting mixture; (c) separating the nonadsorbed fraction from the adsorbed fraction of the incubated mixture of step (b); (d) applying the microorganism as constituting an insoluble, opaque, directly observable form of the antigen to the adsorbed fraction; and (e) observing directly the extent to which the insoluble opaque antigen is bound to the adsorbed fraction by observing the distribution of the antigen on the wall of the container.
Claim 3
Dependent Claim
14 words
The immunoassay of claim 1 wherein the body fluid is a human body fluid.
Claim 4
Dependent Claim
18 words
The immunoassay of claim 1 wherein the antigen is an antigen that is associated with a human disease.
Claim 5
Dependent Claim
17 words
The immunoassay of claim 1 wherein the antigen is an antigen that is associated with Toxoplasma gondii.
Claim 6
Dependent Claim
38 words
A test kit for carrying out the immunoassay of claim 1 comprising, separately provided: (a) an antibody against the Ig; and (b) a preparation of whole microorganisms as constituting an insoluble, opaque, directly observable form of the antigen.
Claim 7
Dependent Claim
14 words
The immunoassay of claim 1 wherein the Ig is a specific class of Ig.
Claim 8
Dependent Claim
14 words
The immunoassay of claim 6 wherein the body fluid is a human body fluid.
Claim 9
Dependent Claim
36 words
A test kit for carrying out the immunoassay of claim 6 comprising separately provided: (a) an antibody against the Ig; and (b) a preparation of whole microorganisms as constituting an insoluble opaque form of the antigen.
Claim 10
Dependent Claim
10 words
The immunoassay of claim 1 wherein the Ig is IgM.
Claim 11
Dependent Claim
14 words
The immunoassay of claim 9 wherein the body fluid is a human body fluid.
Claim 12
Dependent Claim
37 words
A test kit for carrying out the immunoassay of claim 9 comprising separately provided: (a) an antibody against the Ig; and (b) a preparation of whole microorganisms as constituting an insoluble opaque nontranslucent form of the antigen.
Claim 13
Dependent Claim
121 words
An immunoassay for detecting IgM associated with an acute form of Toxoplasma gondii infection in a sample of human body fluid comprising the steps of: (a) adsorbing antihuman IgM antibody onto the solid surface of a well-shaped container; (b) applying the sample to the adsorbed antihuman IgM antibody and incubating the resulting mixture; (c) separating the nonadsorbed fraction from the adsorbed fraction of the incubated mixture; (d) applying a preparation of whole Toxoplasma gondii organisms as constituting an insoluble, opaque, directly observable form of Toxoplasma gondii antigen to the adsorbed fraction at a basic pH and incubating the resulting mixture; and (e) observing directly the extent to which the antigen is bound to the antigen on the wall of the container.
Claim 14
Dependent Claim
121 words
An immunoassay for detecting IgM associated with an acute form of Toxoplasma gondii infection in a sample of human body fluid comprising the steps of: (a) adsorbing antihuman IgM antibody onto the solid surface of a well-shaped container; (b) applying the sample to the adsorbed antihuman IgM antibody and incubating the resulting mixture; (c) separating the nonadsorbed fraction from the adsorbed fraction of the incubated mixture; (d) applying a preparation of whole Toxoplasma gondii organisms as constituting an insoluble, opaque, directly observable form of Toxoplasma gondii antigen to the adsorbed fraction at a basic pH and incubating the resulting mixture; and (e) observing directly the extent to which the antigen is bound to the antigen on the wall of the container.
Claim 15
Dependent Claim
19 words
The immunoassay of claim 13 wherein between steps (a) and (b) the surface is post-coated with an appropriate protein.
Claim 16
Dependent Claim
13 words
The immunoassay of claim 12 wherein the pH is 8.2 to 8.7, inclusive.
Claim 17
Dependent Claim
39 words
A test kit for carrying out the immunoassay of claim 12 comprising, separately provided (a) antihuman IgM antibody; and (b) a preparation of whole Toxoplasma gondii organisms which constitutes an insolubilized, opaque, directly observable form of Toxoplasma gondii antigen.
Claim 18
Dependent Claim
123 words
An immunoassay for detecting, in a sample of body fluid, an Ig that binds specifically to an antigen comprising the steps of: (a) adsorbing an antibody against said Ig and specific for the class of the Ig onto the solid surface of a well-shaped container; (b) applying the sample to the adsorbed antibody against said Ig and incubating the resulting mixture; (c) separating the nonadsorbed fraction from the adsorbed fraction of the incubated mixture of step (b); (d) applying an insoluble, opaque, directly observable form of the antigen to the adsorbed fraction; and (e) observing directly the extent to which the insoluble, opaque antigen is bound to the adsorbed fraction by observing the distribution of the antigen on the wall of the container.
Claim 19
Dependent Claim
123 words
An immunoassay for detecting, in a sample of body fluid, an Ig that binds specifically to an antigen comprising the steps of: (a) adsorbing an antibody against said Ig and specific for the class of the Ig onto the solid surface of a well-shaped container; (b) applying the sample to the adsorbed antibody against said Ig and incubating the resulting mixture; (c) separating the nonadsorbed fraction from the adsorbed fraction of the incubated mixture of step (b); (d) applying an insoluble, opaque, directly observable form of the antigen to the adsorbed fraction; and (e) observing directly the extent to which the insoluble, opaque antigen is bound to the adsorbed fraction by observing the distribution of the antigen on the wall of the container.
Claim 20
Dependent Claim
29 words
The immunoassay of claim 16 wherein the insoluble, opaque directly observable form of the antigen is a whole organism or antigen fixed to the surface of a particulate carrier.
Claim 21
Dependent Claim
19 words
The immunoassay of claim 17 wherein the insoluble, opaque, directly observable form of the antigen is a whole microorganism.
Claim 22
Dependent Claim
12 words
The immunoassay of claim 18 wherein the whole microorganism is Toxoplasma gondii.
Claim 23
Dependent Claim
10 words
The immunoassay of claim 16 wherein the Ig is IgM.
Claim 24
Dependent Claim
28 words
A test kit for carrying out the immunoassay of claim 20 comprising, separately provided (a) antihuman IgM antibody; and (b) an insolubilized, opaque, directly observable form of antigen.
Claim 25
Dependent Claim
22 words
The test kit of claim 21 wherein the insoluble, opaque, directly observable form of the antigen is a preparation of whole microorganisms.
References Cited (Backward Citations)
US3562384A
Cited
US3415361A
Cited
US3853467A
Cited
US3904367A
Cited
US4092116A
Cited
US4169138A
Cited
US3979509A
Cited
US4041146A
Cited
US3979184A
Cited
US4189466A
Cited
US4407943A
Cited
US4115543A
Cited
US4292403A
Cited
US4297004A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-09-15 | 1990-03-17 | 1990-09-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-09-15 | 1994-03-17 | 1994-09-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-09-15 | 1998-03-17 | 1998-09-16 | $7700.00 | Window Closed / Lapsed |